Next Article in Journal
Leriche Syndrome Misdiagnosed as Complex Regional Pain Syndrome in a Patient with Neuropathic Pain Caused by a Chip Fracture: A Case Report
Next Article in Special Issue
The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives
Previous Article in Journal
Diagnosis of Cardiac Abnormalities in Muscular Dystrophies
Previous Article in Special Issue
ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 57
Issue 5
10.3390/medicina57050489
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD

by
Giulio Emilio Brancati
1,
Margherita Barbuti
1,
Elisa Schiavi
2,
Paola Colombini
1,
Martina Moriconi
1,
Alessandro Pallucchini
1,
Marco Maiello
1,
Giulia Menculini
3 and
Giulio Perugi
1,2,*
1
Psychiatry 2 Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy
2
Psychiatry 2 Unit, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126 Pisa, Italy
3
Division of Psychiatry, Department of Medicine, University of Perugia, Piazzale Lucio Severi 1, 06132 Perugia, Italy
*
Author to whom correspondence should be addressed.
Medicina 2021, 57(5), 489; https://doi.org/10.3390/medicina57050489
Submission received: 9 March 2021 / Revised: 20 April 2021 / Accepted: 10 May 2021 / Published: 12 May 2021
(This article belongs to the Special Issue Bipolar Disorder – New Opportunities and Challenges)
Browse Figure
Versions Notes

Abstract

:
Background and Objectives: Emotional dysregulation is central to the problem of the overlap between attention-deficit/hyperactivity disorder (ADHD) and cyclothymia. The aim of the study was to evaluate comorbidity rates between ADHD and cyclothymic disorder and to explore demographic and clinical differences among the groups, focusing on affective temperament and emotional dysregulation. Materials and Methods: One hundred sixty-five outpatients attending the Second Psychiatry Unit at the Santa Chiara University Hospital (Pisa) were consecutively recruited: 80 were diagnosed with ADHD, 60 with cyclothymic disorder, and 25 with both conditions. Temperament Evaluation of Memphis, Pisa, Paris, and San Diego (TEMPS-M) and the 40-item version of Reactivity, Intensity, Polarity, and Stability questionnaire (RI-PoSt-40) were administered. Results: Cyclothymic patients were more frequently female and older with respect to the ADHD groups. Both comorbid and non-comorbid ADHD patients showed significantly lower educational attainment and more frequently had substance use disorders. Panic disorder was common in non-comorbid cyclothymic patients, who showed significantly higher rates of familial panic disorder, major depressive disorder and suicide attempts in comparison with patients only diagnosed with ADHD. Cyclothymic patients without ADHD were also characterized by fewer hyperthymic temperamental traits, higher depressive and anxious dispositions, and a greater negative emotionality. No significant differences among groups were observed for cyclothymic temperament and overall negative emotional dysregulation, but comorbid patients with both conditions scored the highest in these subscales. This group also showed significantly higher affective instability with respect to ADHD patients without cyclothymia and was less frequently diagnosed with bipolar disorder type II than patients from both the other groups. Conclusions: ADHD and cyclothymia often co-occur and show similar levels of emotional dysregulation. However, cyclothymic patients may be more prone to negative emotionality in clinical settings. Subjects with “sunny” cyclothymic features might escape the attention of clinicians unless ADHD is present.

1. Introduction

The failure to regulate emotions, namely emotional dysregulation, is a novel dimension of interest in psychiatric research, which characterizes a multitude of conditions usually observed in clinical practice. Emotional dysregulation shows heterogeneity in its nomenclature, definition, and presentation and can be broadly defined as “rapid oscillations of intense affect, with a difficulty in regulating these oscillations or their behavioural consequences” [1]. Issues in differential diagnoses between attention-deficit/hyperactivity disorder (ADHD) and bipolar spectrum disorders often involve emotional dysregulation [2,3].
ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity, which first appears during childhood and, in approximately half of the cases [4], persists into adulthood. Since problems with regulation of emotions are longitudinally associated with increased psychiatric comorbidity and ADHD persistence [5,6], up to 70% of adults diagnosed with ADHD also show emotional dysregulation [7]. As a consequence, different authors consider it as a core feature of adult ADHD [8,9,10].
At the same time, emotional dysregulation has been long considered a distinctive constitutional trait underlying cyclothymic temperamental variants associated with bipolar affective disorders [11]. Cyclothymic temperament, indeed, has been operationally defined as a constellation of habitual subsyndromal biphasic mood swings with typical abrupt shifts from one phase to another, associated with both subjective and behavioral manifestations, pertaining to interepisodic and premorbid periods of affective disorders [12]. Cyclothymic temperament has been shown to negatively affect illness course [13,14,15] and in its extreme presentations actually constitutes a disabling mood disorder on its own [16]. In these patients, mood reactivity and emotional dysregulation represent the core symptomatology, often beginning very early in childhood [11].
Both ADHD and bipolar spectrum disorders share a difficulty in modulating emotionally driven behavioral responses. Accordingly, a plausible common neurophysiological basis has been hypothesized, involving neurodevelopmental dysfunctions of amygdala and fronto-limbic circuitries [7,17,18]. However, studies assessing the comorbidity between ADHD and cyclothymic disorder are lacking, and it has not been investigated whether ADHD and cyclothymia share the same manifestations of emotional dysregulation or single facets could distinguish among these disorders.
The recently developed Reactivity, Intensity, Polarity, and Stability questionnaire could represent a useful self-report tool to quantify emotional dysregulation in some of its different facets both in psychiatric patients and healthy subjects [19]. We recently validated a 40-item version of the scale (RIPoSt-40), which includes four subscales measuring affect oscillation over time (affective instability), tendency for more intense and frequent negative and positive feelings (negative and positive emotionality), and inability to regulate impulsive behavioral responses to emotionally salient stimuli (emotional impulsivity) [20]. Both patients affected by ADHD and patients affected by cyclothymic disorder were included among validation samples, and marginally significant differences between the groups emerged in emotional impulsivity, with higher scores in those with ADHD, while both clinical groups shared large deviations from the non-clinical sample [20]. However, comorbidity between ADHD and cyclothymia was not taken into consideration.
The first aim of the present study was to evaluate comorbidity rates between ADHD and cyclothymic disorder in outpatients attending the Psychiatry 2 Unit at Santa Chiara University Hospital in Pisa. Second, we explored demographic and clinical differences among patients diagnosed with ADHD, cyclothymia, or both disorders. Special attention was given to affective temperamental dispositions and emotional dysregulation facets.

2. Materials and Methods

According to a naturalistic approach, patients were consecutively enrolled between January 2018 and June 2019 at the Outpatient Service of the Psychiatry 2 Unit of Santa Chiara University Hospital (Pisa, Italy). All subjects provided written informed consent for the study participation. The study was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki), and the study protocol was approved by the Ethical Committee of the University of Pisa on 15 March 2018 (N. 12712_PERUGI).
Adult patients (age ≥ 18 years) receiving a diagnosis of ADHD in accordance with structured Diagnostic Interview for Adult ADHD, second edition (DIVA 2.0), and/or meeting criteria A-B and D-G for cyclothymic disorder from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), were included in the study. Exclusion criterion C for cyclothymic disorder was not applied, and a lifetime history of major mood episodes, whether depressive or (hypo)manic, did not rule out the diagnosis. In contrast, patients presenting with current major depressive or (hypo)manic episodes were excluded. This approach permitted the inclusion of patients with a cyclothymic background, otherwise diagnosed with major depressive, bipolar II, or bipolar I disorder, who experience frequent mood shifts, mild to moderate symptoms, and significant distress and functional impairment. In addition, an early undetermined onset of cyclothymia (<21 years old) was considered mandatory, in accordance with Akiskal and Mallya criteria for cyclothymia [12], to exclude patients with iatrogenic or residual mood swings. Patients with intellectual disability and/or schizophrenia spectrum disorders according to DSM-5 criteria were excluded from the samples.
Socio-demographic variables and lifetime psychiatric comorbidity according to DSM-5 criteria were assessed in a single consultation by the participating psychiatrists. Affective temperamental traits were measured by means of the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego (TEMPS-M) [21,22], a self-evaluation form of 35 items coded on a 5-point Likert scale (from absent to very much) and including five subscales, one for each affective temperamental disposition, namely depressive, cyclothymic, hyperthymic, irritable, and anxious. Emotional dysregulation was measured using the Reactivity, Intensity, Polarity, and Stability questionnaire in its 40-item version (RIPoSt-40) [20]. Items rated on a Likert scale ranging from 1 (“never”) to 6 (“always”) were summed to compute four subscales scores, assessing affective instability, positive and negative emotionality, and emotional impulsivity, and a second-order negative emotional dysregulation score made up of affective instability, negative emotionality, and emotional impulsivity subscales. A new index was also computed as the ratio between negative and positive emotionality subscale scores (NE/PE ratio).
All the statistical analyses were performed using IBM SPSS Statistics for Mac, Version 25.0 (SPSS Inc., Chicago, IL, USA). Demographic and clinical variables as well as RIPoSt-40 and TEMPS-M scores were compared among the groups. Descriptive statistics (mean, standard deviation (SD)) were used to describe characteristics of the subsamples. Comparative analyses were conducted using chi-square test for categorical variables (with z-test contrasts and Bonferroni’s correction) and one-way analysis of variance (ANOVA) for continuous variables (with a posteriori contrasts according to Scheffé’s procedure). Finally, a principal component analysis (PCA) with varimax rotation was performed on TEMPS-M and RIPoSt-40 subscales. All the components with an eigenvalue greater than 1 were retained, according to Kaiser criterion [23], and compared among the groups. The significance level in all statistical tests was set to 0.05.

3. Results

A sample of 165 patients was recruited: 80 of them were diagnosed with ADHD, 60 with cyclothymic disorder, and 25 with both ADHD and cyclothymic disorder. Significant differences in age, gender, and educational level were observed among these groups (Table 1). Cyclothymic patients without ADHD showed a significantly higher age in comparison with patients only diagnosed with ADHD, while comorbid patients had intermediate age and did not significantly differ from both the other groups. Instead, all the groups significantly differed from each other in terms of gender proportions. Women were overrepresented in the cyclothymic group without ADHD and underrepresented in the ADHD group, with an intermediate rate in comorbid ADHD–cyclothymic patients. Both comorbid and non-comorbid ADHD patients showed significantly lower educational attainment as compared with non-comorbid cyclothymia: university or superior educational level was more frequently observed in cyclothymic patients than in the other groups, while both ADHD and ADHD–cyclothymic patients more frequently showed a primary or middle school educational level as compared with cyclothymic patients.
Bipolar disorders were common among all the groups, being diagnosed in 83 of 165 patients (50.3%). No significant differences in bipolar disorder type I prevalence were found among the groups. However, bipolar disorder type II was more frequently diagnosed in non-comorbid ADHD and cyclothymia than in comorbid ADHD–cyclothymic patients. Substance use disorders were significantly more frequently observed in both the ADHD groups, which showed a prevalence approximately twice that reported in non-comorbid cyclothymic patients (63.8% vs. 28.3%). The opposite pattern was observed for panic disorder, though not significantly (p = 0.060): in patients with cyclothymia, whether comorbid with ADHD or not, panic disorder was almost twice as prevalent as in patients only affected by ADHD (28.2% vs. 15.0%).
Approximately a half of patients had a first-degree family history of bipolar disorder (75 of 165, 45.5%), without significant differences among the groups. As for the other disorders, first-degree family history showed patterns that were similar to those observed for psychiatric comorbidity. On one hand, the highest rate of familial substance use disorders was found in ADHD patients, and the lowest was found in non-comorbid cyclothymic patients. Comorbid ADHD–cyclothymic patients showed an intermediate rate. However, these differences failed to reach statistical significance (p = 0.064). On the other hand, familial panic disorder was significantly more frequent in non-comorbid cyclothymic patients than in non-comorbid ADHD, while comorbid patients had an intermediate rate and did not significantly differ from both the other groups. Importantly, a similar pattern of significant differences was found for familial major depressive disorder and suicide attempts.
While no significant differences were found for cyclothymic and irritable temperamental dimensions, depressive, hyperthymic, and anxious temperament scores from TEMPS-M significantly differed among groups (Table 2). Patients with cyclothymia without ADHD obtained significantly higher scores than patients only diagnosed with ADHD on both the depressive and anxious temperament subscales. Conversely, the hyperthymic temperament score was significantly higher in non-comorbid ADHD as compared with non-comorbid cyclothymia. The comorbid ADHD-cyclothymia group showed intermediate scores of depressive, anxious, and hyperthymic temperaments but the highest scores of cyclothymic and irritable temperaments among the groups.
Among emotional dysregulation facets measured by RIPoSt-40, affective instability and negative emotionality significantly differed among the groups, while positive emotionality, emotional impulsivity, and overall negative emotional dysregulation did not show significantly different scores. As for affective instability, comorbid patients with ADHD and cyclothymia scored significantly higher than patients with only ADHD. Negative emotionality, instead, was significantly higher in cyclothymic patients without ADHD as compared with non-comorbid ADHD patients. As for NE/PE ratio, a significant deviation from balanced emotional polarities emerged in the whole sample, with a prominence of negative over positive emotionality using one-sample t-test (test = 1, t = 2.29, p = 0.023; Figure 1). As for negative emotionality, NE/PE ratio was significantly higher in cyclothymic patients without ADHD as compared with non-comorbid ADHD patients.
Finally, two components, explaining 63.74% of the variance, were extracted through PCA with varimax rotation performed on TEMPS-M and RIPoSt-40 subscales (Table 3). Cyclothymic, depressive, and anxious temperaments were mainly loaded together with affective instability, negative emotionality, and emotional impulsivity in the first component, which explained 45.18% of the variance and was interpreted as representing negative affect dysregulation. Hyperthymic temperament and positive emotionality were mainly loaded in the second component, which explained 18.56% of the variance and was interpreted as representing positive affect. Irritable temperament was mainly loaded in the first component but also showed a medium loading in the second one. Significant differences among diagnostic groups were found in both the negative (F = 4.36, p = 0.014) and positive components (F = 8.71, p < 0.001). Patients only diagnosed with cyclothymia scored significantly higher on the first component than patients with only ADHD (z-scores (mean ± SD): 0.23 ± 0.98 vs. −0.23 ± 0.96), while comorbid patients with both diagnoses did not significantly differ from the others (z-score (mean ± SD): 0.18 ± 1.04). Conversely, both comorbid and non-comorbid ADHD groups had significantly higher scores for positive affect than patients with non-comorbid cyclothymia. The highest score was found in patients with both ADHD and cyclothymia, followed, in order, by ADHD and cyclothymia (z-scores (mean ± SD): 0.34 ± 1.03; 0.20 ± 0.91; −0.40 ± 0.97).

4. Discussion

In our study, we consecutively recruited adult psychiatric outpatients diagnosed with ADHD and/or cyclothymic disorder. Importantly, a high diagnostic overlap among categories was observed. Indeed, approximately one-fourth of all the ADHD patients included in the study also presented with cyclothymic disorder (25 of 85, 23.8%). This latter rate doubles the lifetime prevalence of bipolar disorder in ADHD samples, which approximately settles to 10% according to recent estimates [24]. A selection bias could be assumed, given that the sample was clinically referred to a tertiary level service specialized in mood disorders. However, cyclothymic temperament has been previously reported, on average, in 18% of adult ADHD patients recruited in other clinical settings [25,26] and in more than half of subjects with a positive screening for ADHD in a recent epidemiological study [27].
Among cyclothymic patients recruited in our study, almost a third were diagnosed with ADHD (25 of 60, 29.4%). This figure outweighs the estimated prevalence of ADHD in adults with bipolar disorder, which nearly reaches 20% based on recent meta-analytic findings [28]. However, as far as we know, no study so far has specifically investigated the comorbidity between ADHD and cyclothymic disorder, even if symptomatologic similarities have been previously observed [20]. In addition, to the best of our knowledge, this is the first study that compared patients diagnosed with ADHD, patients diagnosed with cyclothymic disorder, and comorbid patients with both disorders.
The greatest differences were observed between non-comorbid patient groups (i.e., ADHD only vs. cyclothymia only). Cyclothymic patients were more frequently female, were older, and more frequently achieved a high educational level. ADHD patients, instead, were more frequently male, were younger, and had lower educational achievements. ADHD patients with comorbid cyclothymia showed a similarly low educational attainment, which suggests a higher impact of attentional and hyperactive–impulsive dimensions, rather than affective symptoms, on academic achievements. Indeed, even if emotional impulsivity has been previously associated with educational outcomes, including high school and college graduation, in adults with ADHD [29], attentional problems and executive dysfunctions have been repeatedly found to predict school performance and academic achievement in prospective studies conducted in children and adolescent samples [30,31,32,33].
Substance use disorders were also specifically associated with ADHD, regardless of the presence of cyclothymia. Previous studies consistently supported the association between childhood ADHD and adult substance use disorders based on both prospective assessments [34] and retrospective accounts [35]. Approximately a fourth of patients with substance use disorders are diagnosed with ADHD [36], and among patients with substance use disorders, those with ADHD are more likely to report an early onset of nicotine and illicit drug use, a reduced latency between first use and dependence/abuse, a higher severity of use, more risk behaviors, and functional impairment [37,38]. While ADHD has been implicated in the pathogenesis of substance use disorders [39], the role of cyclothymia is less clear. Cyclothymic temperamental traits have been repeatedly positively associated with substance use disorders both in clinical [40,41,42] and community settings [43,44]. However, null [45] and conflicting findings have also been reported [46] and the role of cyclothymic disorder, rather than temperament, has been understudied. Importantly, studies assessing ADHD as a potential confounder of the relationship between cyclothymia and substance use disorders are lacking. Based on our findings, we posit that the positive association between cyclothymic traits and substance use could be largely mediated by ADHD.
On the opposite, a trend toward higher comorbidity of cyclothymia with panic disorder was observed, and a first-degree family history of panic disorder, major depressive episodes, and suicide attempts were more frequently reported by cyclothymic patients. The relationship between soft bipolar disorders and panic disorder has been long established [47], and panic disorder has been proposed as a marker of genetic heterogeneity in bipolar disorder which could increase the resolution of linkage analyses [48]. In this respect, a familial subtype of bipolar disorder associated with higher rates of panic disorder, cyclothymia, and dysthymia and lower rates of substance use disorders has been isolated [48]. Panic disorder has been associated with cyclothymic and dysthymic temperamental traits in major depressive patients presenting with atypical features [49] and with short hypomanic episodes in patients with recurrent brief depressions [50]. In contrast, only a few studies have assessed panic comorbidity in adults with ADHD, and conflicting findings have emerged from comparisons with healthy controls [51,52]. In addition, panic disorder has been demonstrated as the least prevalent anxiety disorder in children with ADHD [53], and polygenic risk for ADHD has been negatively associated with panic disorder in a Japanese study [54]. Building on our results, we hypothesize that an increased rate of panic disorder could be observed in adult ADHD patients with respect to healthy controls. However, we also posit this difference to be largely explained by comorbid cyclothymia. Indeed, panic disorder in adult ADHD patients has been associated with female gender [52] and with bipolar comorbidity [55], and anxiety comorbidity in children with ADHD has been prospectively associated with bipolar disorder in a recent register-based ecological study [56].
Overall, the differences observed in familial history suggest a higher genetic load for conditions associated with negative affect and harm avoidance in patients with cyclothymia with respect to ADHD patients, whose pattern of comorbidity is indicative of a greater inclination toward sensation seeking. Indeed, ADHD has been repeatedly characterized by high novelty seeking [57], while both harm avoidance and novelty seeking coexist with cyclothymic temperament [58]. These differences are also reflected in affective temperamental traits and emotional dysregulation facet variations among patients included in our study. In comparison with ADHD patients, cyclothymic patients without ADHD were characterized by fewer hyperthymic temperamental traits, higher depressive and anxious dispositions, and greater negative emotionality and NE/PE ratio, despite similar scores on irritable temperament subscale and emotional impulsivity. These findings could be partially mediated by differences in age and gender among the groups, since women usually score lower than men in hyperthymic temperament and higher in anxious and depressive temperaments, with the latter increasing with age [59]. However, given the limited sample size, the impact of gender differences on affective temperament discrepancies could not be properly ascertained in our study.
Differences in affective temperamental traits and negative emotionality could also be attributed to different triggers for referral to psychiatric services. In our context, approximately one-fifth of patients diagnosed with ADHD during childhood or adolescence continue to use mental health services in adulthood [60], a rate similar to that observed in the United Kingdom [61]. Most patients are referred to our service for ADHD assessment due to a long-standing pattern of impulsive behavior and drug abuse. Medication resistance can also represent a major reason for referral. Finally, a subgroup of ADHD patients may access our service after repeated academic failures, occupational difficulties, and vocational impairment, which can be traced back to attentional deficits. On the other hand, cyclothymic patients mainly consult psychiatric facilities when mood and anxiety comorbidity occur [11]. Based on these assumptions, we can speculate that only a subgroup of cyclothymic subjects, predominantly characterized by anxious and dysthymic traits and problems with negative emotionality, reaches clinical attention [62], while subjects with hyperthymic variants of cyclothymia are less prone to experience significant distress due to affective fluctuations and may also show a good-to-excellent functioning [63]. These “sunny” cyclothymic conditions are unlikely to be encountered in clinical settings, unless associated with other sources of functional impairment such as ADHD. Future community studies could help to confirm or disprove this hypothesis.
Interestingly, while no significant differences among our groups were observed for cyclothymic temperament and overall negative emotional dysregulation, comorbid patients with both ADHD and cyclothymia scored the highest in these subscales. In addition, this group also showed higher affective instability with respect to ADHD patients without cyclothymia and was less frequently diagnosed with bipolar disorder type II than patients from both the other groups. This could be due to conservative attitudes toward diagnosis: since clinicians may be less prone to diagnose a patient with both ADHD and cyclothymic disorder due to overlapping symptoms of these conditions, only ADHD patients showing really severe, rapid, and frequent mood swings, which are reflected in greater affective instability scores and fail to reach duration thresholds for hypomanic episodes, may receive the diagnosis of “comorbid” cyclothymic disorder. We suggest that these patients are likely to be characterized by “dark” unstable expressions of soft bipolarity and to be diagnosed as affected by borderline personality disorder, which highly overlaps both with ADHD and bipolar disorder [64]. Indeed, it has been previously hypothesized that borderline personality traits could represent, in some cases, expressions of a developmental bipolar subtype [65,66] stemming from extreme mood lability and interpersonal sensitivity associated with cyclothymic temperament [67]. At this point, we further speculate that a considerable proportion of cases of borderline personality disorder may arise from overlapping ADHD and cyclothymia diatheses, whose expressions are mediated by developmental stages as previously hinted by Michael H. Stone [17]. While this hypothesis warrants further investigation, we are confident that a neurodevelopmentally oriented approach and a lifespan perspective could help promote accurate diagnosis and improved care of this difficult-to-treat population.
Several limitations of this study should be acknowledged. First, the clinical setting (a tertiary psychiatry unit) may have not been representative of the whole population of patients with ADHD and/or cyclothymia, but of a more complicated subpopulation, possibly showing higher rates of comorbidity and a greater severity. Second, the cross-sectional study design mostly limited the assessment of psychiatric comorbidity to retrospective accounts, which may be at risk of recall bias. In addition, the evaluation of affective temperaments and emotional dysregulation facets was based on self-report questionnaires, which may be biased by differences in social desirability, lack of insight, or malingering attempts. Finally, the criteria used to identify patients affected by cyclothymia slightly differed from DSM-5 criteria, possibly being more inclusive. As a consequence, our results should be interpreted with caution. Further longitudinal studies on epidemiological samples are needed to investigate comorbidity rates and psychopathological differences between ADHD and cyclothymia, possibly including different definitions of the latter disorder.

5. Conclusions

To the best of our knowledge, this is the first study to investigate the comorbidity between ADHD and cyclothymic disorder in adult clinical samples and compare patients diagnosed with either one or both of the disorders. Based on our findings, ADHD and cyclothymic disorder often co-occur. While differences can be observed in socio-demographic variables (i.e., age, gender, educational level), emotional dysregulation is a common feature in both conditions, with a slightly greater severity in patients diagnosed with both disorders. Based on psychiatric comorbidity, family history, and differences in affective temperaments and emotional dysregulation facets, cyclothymic patients were found to be significantly more prone to negative emotions, such as anxiety and depressed mood, in comparison with patients affected by ADHD, more often comorbid with substance use disorders. However, these differences could be limited to the clinical setting, where different reasons for referral are likely to bias sample selection. Patients with ADHD without emotional dysregulation and subjects with “sunny” cyclothymic temperament might be found in the community. On this assumption, we propose that the co-occurrence of conditions within the attention-deficit/hyperactivity and cyclothymic spectra can be summarized according to non-orthogonal, but also non-overlapping, intersected dimensions of deficient executive functioning and negative emotionality in adults with emotional dysregulation, both of which are likely to influence clinical attention. Alternatively, different emotional dispositions characterize patients with ADHD or cyclothymia. While positive affect could counterbalance negative emotionality in the former group, depressive and anxious tendencies may prevail in the latter.

Author Contributions

M.B., E.S., P.C., M.M. (Martina Moriconi), A.P., and M.M. (Marco Maiello) were involved in patient recruitment and evaluation; G.E.B. managed literature searches, undertook statistical analysis, and wrote the first draft; M.B. and G.M. contributed to the writing of the final draft; G.P. designed the study, coordinated the project, and supervised the final draft. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of the University of Pisa (N. 12712_PERUGI).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are available on request from the corresponding author.

Conflicts of Interest

Perugi acted as consultant to Lundbeck, Angelini, and FB-Health. He received a scholarship/research support from Lundbeck and Angelini. He is a member of the speaker/advisory board of Sanofi-Aventis, Lundbeck, FB-Health, and Angelini. Other authors have no affiliation or financial interest in any organization that may constitute a conflict of interest.

References

  1. Marwaha, S.; He, Z.; Broome, M.; Singh, S.P.; Scott, J.; Eyden, J.; Wolke, D. How Is Affective Instability Defined and Measured? A Systematic Review. Psychol. Med. 2014, 44, 1793–1808. [Google Scholar] [CrossRef] [Green Version]
  2. Skirrow, C.; Asherson, P. Emotional Lability, Comorbidity and Impairment in Adults with Attention-Deficit Hyperactivity Disorder. J. Affect. Disord. 2013, 147, 80–86. [Google Scholar] [CrossRef]
  3. Asherson, P.; Young, A.H.; Eich-Höchli, D.; Moran, P.; Porsdal, V.; Deberdt, W. Differential Diagnosis, Comorbidity, and Treatment of Attention-Deficit/Hyperactivity Disorder in Relation to Bipolar Disorder or Borderline Personality Disorder in Adults. Curr. Med. Res. Opin. 2014, 30, 1657–1672. [Google Scholar] [CrossRef]
  4. Biederman, J.; Petty, C.R.; Evans, M.; Small, J.; Faraone, S.V. How Persistent Is ADHD? A Controlled 10-Year Follow-up Study of Boys with ADHD. Psychiatry Res. 2010, 177, 299–304. [Google Scholar] [CrossRef] [Green Version]
  5. Althoff, R.R.; Verhulst, F.C.; Rettew, D.C.; Hudziak, J.J.; van der Ende, J. Adult Outcomes of Childhood Dysregulation: A 14-Year Follow-up Study. J. Am. Acad. Child. Adolesc. Psychiatry 2010, 49, 1105–1116. [Google Scholar] [CrossRef]
  6. Biederman, J.; Spencer, T.J.; Petty, C.; Hyder, L.L.; O’Connor, K.B.; Surman, C.B.; Faraone, S.V. Longitudinal Course of Deficient Emotional Self-Regulation CBCL Profile in Youth with ADHD: Prospective Controlled Study. Neuropsychiatr. Dis. Treat. 2012, 8, 267–276. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Shaw, P.; Stringaris, A.; Nigg, J.; Leibenluft, E. Emotion Dysregulation in Attention Deficit Hyperactivity Disorder. Am. J. Psychiatry 2014, 171, 276–293. [Google Scholar] [CrossRef] [Green Version]
  8. Barkley, R.A. Emotional Dysregulation Is a Core Component of ADHD. In Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment; Barkley, R.A., Ed.; Guilford Press: New York, NY, USA, 2015; pp. 81–115. [Google Scholar]
  9. Skirrow, C.; McLoughlin, G.; Kuntsi, J.; Asherson, P. Behavioral, Neurocognitive and Treatment Overlap between Attention-Deficit/Hyperactivity Disorder and Mood Instability. Expert Rev. Neurother. 2009, 9, 489–503. [Google Scholar] [CrossRef]
  10. Hirsch, O.; Chavanon, M.L.; Riechmann, E.; Christiansen, H. Emotional Dysregulation Is a Primary Symptom in Adult Attention-Deficit/Hyperactivity Disorder (ADHD). J. Affect. Disord. 2018, 232, 41–47. [Google Scholar] [CrossRef] [PubMed]
  11. Perugi, G.; Hantouche, E.; Vannucchi, G. Diagnosis and Treatment of Cyclothymia: The “Primacy” of Temperament. Curr. Neuropharmacol. 2017, 15, 372–379. [Google Scholar] [CrossRef] [Green Version]
  12. Akiskal, H.S.; Mallya, G. Criteria for the “Soft” Bipolar Spectrum: Treatment Implications. Psychopharmacol. Bull. 1987, 23, 68–73. [Google Scholar] [PubMed]
  13. Nilsson, K.K.; Straarup, K.N.; Jørgensen, C.R.; Licht, R.W. Affective Temperaments’ Relation to Functional Impairment and Affective Recurrences in Bipolar Disorder Patients. J. Affect. Disord. 2012, 138, 332–336. [Google Scholar] [CrossRef] [PubMed]
  14. Innamorati, M.; Rihmer, Z.; Akiskal, H.; Gonda, X.; Erbuto, D.; Murri, M.B.; Perugi, G.; Amore, M.; Girardi, P.; Pompili, M. Cyclothymic Temperament Rather than Polarity Is Associated with Hopelessness and Suicidality in Hospitalized Patients with Mood Disorders. J. Affect. Disord. 2015, 170, 161–165. [Google Scholar] [CrossRef]
  15. Mechri, A.; Kerkeni, N.; Touati, I.; Bacha, M.; Gassab, L. Association between Cyclothymic Temperament and Clinical Predictors of Bipolarity in Recurrent Depressive Patients. J. Affect. Disord. 2011, 132, 285–288. [Google Scholar] [CrossRef] [PubMed]
  16. Perugi, G.; Hantouche, E.; Vannucchi, G.; Pinto, O. Cyclothymia Reloaded: A Reappraisal of the Most Misconceived Affective Disorder. J. Affect. Disord. 2015, 183, 119–133. [Google Scholar] [CrossRef]
  17. Stone, M.H. A New Look at Borderline Personality Disorder and Related Disorders: Hyper-Reactivity in the Limbic System and Lower Centers. Psychodyn. Psychiatry 2013, 41, 437–466. [Google Scholar] [CrossRef] [PubMed]
  18. Petrovic, P.; Castellanos, F.X. Top-Down Dysregulation—From ADHD to Emotional Instability. Front Behav. Neurosci. 2016, 10, 1–25. [Google Scholar] [CrossRef] [PubMed]
  19. Hantouche, E.G. Les Tempéraments Affectifs: L’architecture Naturelle de Nos Émotions; Editions Josette Lyon: Paris, France, 2014. [Google Scholar]
  20. Brancati, G.E.; Barbuti, M.; Pallucchini, A.; Cotugno, B.; Schiavi, E.; Hantouche, E.G.; Perugi, G. Reactivity, Intensity, Polarity and Stability Questionnaire (RIPoSt-40) Assessing Emotional Dysregulation: Development, Reliability and Validity. J. Affect. Disord. 2019, 257, 187–194. [Google Scholar] [CrossRef]
  21. Erfurth, A.; Gerlach, A.L.; Hellweg, I.; Boenigk, I.; Michael, N.; Akiskal, H.S. Studies on a German (Münster) Version of the Temperament Auto-Questionnaire TEMPS-A: Construction and Validation of the BriefTEMPS-M. J. Affect. Disord. 2005, 85, 53–69. [Google Scholar] [CrossRef]
  22. Fico, G.; Luciano, M.; Sampogna, G.; Zinno, F.; Steardo, L.; Perugi, G.; Pompili, M.; Tortorella, A.; Volpe, U.; Fiorillo, A.; et al. Validation of the Brief TEMPS-M Temperament Questionnaire in a Clinical Italian Sample of Bipolar and Cyclothymic Patients. J. Affect. Disord. 2020, 260, 458–462. [Google Scholar] [CrossRef] [PubMed]
  23. Kaiser, H.F. The Application of Electronic Computers to Factor Analysis. Educ. Psychol. Meas. 1960, 20, 141–151. [Google Scholar] [CrossRef]
  24. Schiweck, C.; Arteaga-Henriquez, G.; Aichholzer, M.; Edwin Thanarajah, S.E.; Vargas-Cáceres, S.; Matura, S.; Grimm, O.; Haavik, J.; Kittel-Schneider, S.; Ramos-Quiroga, J.A.; et al. Comorbidity of ADHD and Adult Bipolar Disorder: A Systematic Review and Meta-Analysis. Neurosci. Biobehav. Rev. 2021, 124, 100–123. [Google Scholar] [CrossRef] [PubMed]
  25. Torrente, F.; López, P.; Lischinsky, A.; Cetkovich-Bakmas, M.; Manes, F. Depressive Symptoms and the Role of Affective Temperament in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): A Comparison with Bipolar Disorder. J. Affect. Disord. 2017, 221, 304–311. [Google Scholar] [CrossRef] [PubMed]
  26. Ekinci, S.; Özdel, K.; Öncü, B.; Çolak, B.; Kandemir, H.; Canat, S. Temperamental Characteristics in Adults with Attention-Deficit Hyperactivity Disorder: A Comparison with Bipolar Disorder and Healthy Control Groups. Psychiatry Investig. 2013, 10, 137–142. [Google Scholar] [CrossRef] [Green Version]
  27. Syrstad, V.E.G.; Oedegaard, K.J.; Fasmer, O.B.; Halmoy, A.; Haavik, J.; Dilsaver, S.; Gjestad, R. Cyclothymic Temperament: Associations with ADHD, Other Psychopathology, and Medical Morbidity in the General Population. J. Affect. Disord. 2020, 260, 440–447. [Google Scholar] [CrossRef] [PubMed]
  28. Sandstrom, A.; Perroud, N.; Alda, M.; Uher, R.; Pavlova, B. Prevalence of Attention-deficit/Hyperactivity Disorder in People with Mood Disorders: A Systematic Review and Meta-analysis. Acta Psychiatr. Scand. 2021. [Google Scholar] [CrossRef]
  29. Barkley, R.A.; Fischer, M. The Unique Contribution of Emotional Impulsiveness to Impairment in Major Life Activities in Hyperactive Children as Adults. J. Am. Acad. Child. Adolesc. Psychiatry 2010, 49, 503–513. [Google Scholar] [PubMed]
  30. Rennie, B.; Beebe-Frankenberger, M.; Swanson, H.L. A Longitudinal Study of Neuropsychological Functioning and Academic Achievement in Children with and without Signs of Attention-Deficit/ Hyperactivity Disorder. J. Clin. Exp. Neuropsychol. 2014, 36, 621–635. [Google Scholar] [CrossRef] [PubMed]
  31. Galéra, C.; Melchior, M.; Chastang, J.F.; Bouvard, M.P.; Fombonne, E. Childhood and Adolescent Hyperactivity-Inattention Symptoms and Academic Achievement 8 Years Later: The GAZEL Youth Study. Psychol. Med. 2009, 39, 1895–1906. [Google Scholar] [CrossRef] [Green Version]
  32. Evans, S.C.; Cooley, J.L.; Blossom, J.B.; Pederson, C.A.; Tampke, E.C.; Fite, P.J. Examining ODD/ADHD Symptom Dimensions as Predictors of Social, Emotional, and Academic Trajectories in Middle Childhood. J. Clin. Child Adolesc. Psychol. 2020, 49, 912–929. [Google Scholar] [CrossRef] [PubMed]
  33. Efron, D.; Nicholson, J.M.; Anderson, V.; Silk, T.; Ukoumunne, O.C.; Gulenc, A.; Hazell, P.; Jongeling, B.; Sciberras, E. ADHD at Age 7 and Functional Impairments at Age 10. Pediatrics 2020, 146. [Google Scholar] [CrossRef] [PubMed]
  34. Lee, S.S.; Humphreys, K.L.; Flory, K.; Liu, R.; Glass, K. Prospective Association of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD) and Substance Use and Abuse/Dependence: A Meta-Analytic Review. Clin. Psychol. Rev. 2011, 31, 328–341. [Google Scholar] [CrossRef] [Green Version]
  35. De Alwis, D.; Lynskey, M.T.; Reiersen, A.M.; Agrawal, A. Attention-Deficit/Hyperactivity Disorder Subtypes and Substance Use and Use Disorders in NESARC. Addict. Behav. 2014, 39, 1278–1285. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Van Emmerik-van Oortmerssen, K.; van de Glind, G.; van den Brink, W.; Smit, F.; Crunelle, C.L.; Swets, M.; Schoevers, R.A. Prevalence of Attention-Deficit Hyperactivity Disorder in Substance Use Disorder Patients: A Meta-Analysis and Meta-Regression Analysis. Drug Alcohol Depend. 2012, 122, 11–19. [Google Scholar] [CrossRef] [PubMed]
  37. Kousha, M.; Shahrivar, Z.; Alaghband-Rad, J. Substance Use Disorder and ADHD: Is ADHD a Particularly “Specific” Risk Factor? J. Atten. Disord. 2012, 16, 325–332. [Google Scholar] [CrossRef]
  38. Kaye, S.; Gilsenan, J.; Young, J.T.; Carruthers, S.; Allsop, S.; Degenhardt, L.; van de Glind, G.; van den Brink, W. Risk Behaviours among Substance Use Disorder Treatment Seekers with and without Adult ADHD Symptoms. Drug Alcohol Depend. 2014, 144, 70–77. [Google Scholar] [CrossRef] [PubMed]
  39. Wilson, J.J.; Levin, F.R. Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders. J. Child. Adolesc. Psychopharmacol. 2005, 15, 751–763. [Google Scholar] [CrossRef]
  40. Rovai, L.; Maremmani, A.G.I.; Bacciardi, S.; Gazzarrini, D.; Pallucchini, A.; Spera, V.; Perugi, G.; Maremmani, I. Opposed Effects of Hyperthymic and Cyclothymic Temperament in Substance Use Disorder (Heroin- or Alcohol-Dependent Patients). J. Affect. Disord. 2017, 218, 339–345. [Google Scholar] [CrossRef] [PubMed]
  41. Pompili, M.; Innamorati, M.; Lester, D.; Akiskal, H.S.; Rihmer, Z.; del Casale, A.; Amore, M.; Girardi, P.; Tatarelli, R. Substance Abuse, Temperament and Suicide Risk: Evidence from a Case-Control Study. J. Addict. Dis. 2009, 28, 13–20. [Google Scholar] [CrossRef]
  42. Inanli, I.; Ozturk, H.I.; Caliskan, A.M.; Ozbek, S.; Demirel, B.; Er, M.; Eren, I. The Impact of Affective Temperaments on Opioid Dependence and Addiction Severity. Heroin Addict. Relat. Clin. Probl. 2020, 22, 9–16. [Google Scholar]
  43. Unseld, M.; Dworschak, G.; Tran, U.S.; Plener, P.L.; Erfurth, A.; Walter, H.; Lesch, O.M.; Kapusta, N.D. The Concept of Temperament in Psychoactive Substance Use among College Students. J. Affect. Disord. 2012, 141, 324–330. [Google Scholar] [CrossRef]
  44. Infortuna, C.; Silvestro, S.; Crenshaw, K.; Muscatello, M.R.A.; Bruno, A.; Zoccali, R.A.; Chusid, E.; Intrator, J.; Han, Z.; Battaglia, F. Affective Temperament Traits and Age-Predicted Recreational Cannabis Use in Medical Students: A Cross-Sectional Study. Int. J. Environ. Res. Public Health 2020, 17, 4836. [Google Scholar] [CrossRef]
  45. Perrini, F.; Matrone, M.; de Bartolomeis, A.; Montano, A.; Amici, E.; Callovini, G.; Cuomo, I.; de Persis, S.; Lombardozzi, G.; Battagliese, G.; et al. Developmental Trajectories in Psychiatric Disorders: Does Substance/Alcohol Use Moderate the Effects of Affective Temperaments as Moderators of Age at Onset? A Study in Post-Acute, Hospitalized Patients with Psychotic or DSM-5 Bipolar or Major Depressive Disorders. J. Addict. Dis. 2021, 1–22. [Google Scholar] [CrossRef]
  46. Yehya, Y.; Haddad, C.; Obeid, S.; Tahan, F.; Nabout, R.; Hallit, S.; Kazour, F. Affective Temperaments in Lebanese People with Substance Use Disorder. Perspect. Psychiatr. Care 2019, 55, 478–485. [Google Scholar] [CrossRef]
  47. Savino, M.; Perugi, G.; Simonini, E.; Soriani, A.; Cassano, G.B.; Akiskal, H.S. Affective Comorbidity in Panic Disorder: Is There a Bipolar Connection? J. Affect. Disord. 1993, 28, 155–163. [Google Scholar] [CrossRef]
  48. MacKinnon, D.F.; McMahon, F.J.; Simpson, S.G.; McInnis, M.G.; DePaulo, J.R. Panic Disorder with Familial Bipolar Disorder. Biol. Psychiatry 1997, 42, 90–95. [Google Scholar] [CrossRef]
  49. Akiskal, H.S.; Akiskal, K.K.; Perugi, G.; Toni, C.; Ruffolo, G.; Tusini, G. Bipolar II and Anxious Reactive “Comorbidity”: Toward Better Phenotypic Characterization Suitable for Genotyping. J. Affect. Disord. 2006, 96, 239–247. [Google Scholar] [CrossRef]
  50. Lövdahl, H.; Andersson, S.; Hynnekleiv, T.; Malt, U.F. The Phenomenology of Recurrent Brief Depression with and without Hypomanic Features. J. Affect. Disord. 2009, 112, 151–164. [Google Scholar] [CrossRef] [PubMed]
  51. O’Rourke, S.R.; Bray, A.C.; Anastopoulos, A.D. Anxiety Symptoms and Disorders in College Students With ADHD. J. Atten. Disord. 2020, 24, 1764–1774. [Google Scholar] [CrossRef] [Green Version]
  52. Cumyn, L.; French, L.; Hechtman, L. Comorbidity in Adults with Attention-Deficit Hyperactivity Disorder. Can. J. Psychiatry 2009, 54, 673–683. [Google Scholar] [CrossRef] [Green Version]
  53. Eser, H.Y.; Kacar, A.S.; Kilciksiz, C.M.; Yalcinay-Inan, M.; Ongur, D. Prevalence and Associated Features of Anxiety Disorder Comorbidity in Bipolar Disorder: A Meta-Analysis and Meta-Regression Study. Front. Psychiatry 2018, 9. [Google Scholar] [CrossRef] [Green Version]
  54. Ohi, K.; Otowa, T.; Shimada, M.; Sugiyama, S.; Muto, Y.; Tanahashi, S.; Kaiya, H.; Nishimura, F.; Sasaki, T.; Tanii, H.; et al. Shared Transethnic Genetic Basis of Panic Disorder and Psychiatric and Related Intermediate Phenotypes. Eur. Neuropsychopharmacol. 2021, 42, 87–96. [Google Scholar] [CrossRef] [PubMed]
  55. Karaahmet, E.; Konuk, N.; Dalkilic, A.; Saracli, O.; Atasoy, N.; Kurçer, M.A.; Atik, L. The Comorbidity of Adult Attention-Deficit/Hyperactivity Disorder in Bipolar Disorder Patients. Compr. Psychiatry 2013, 54, 549–555. [Google Scholar] [CrossRef] [PubMed]
  56. Meier, S.M.; Pavlova, B.; Dalsgaard, S.; Nordentoft, M.; Mors, O.; Mortensen, P.B.; Uher, R. Attention-Deficit Hyperactivity Disorder and Anxiety Disorders as Precursors of Bipolar Disorder Onset in Adulthood. Br. J. Psychiatry 2018, 213, 555–560. [Google Scholar] [CrossRef] [PubMed]
  57. Pinzone, V.; De Rossi, P.; Trabucchi, G.; Lester, D.; Girardi, P.; Pompili, M. Temperament Correlates in Adult ADHD: A Systematic Review. J. Affect. Disord. 2019, 252, 394–403. [Google Scholar] [CrossRef]
  58. Maremmani, I.; Akiskal, H.S.; Signoretta, S.; Liguori, A.; Perugi, G.; Cloninger, R. The Relationship of Kraepelian Affective Temperaments (as Measured by TEMPS-I) to the Tridimensional Personality Questionnaire (TPQ). J. Affect. Disord. 2005, 85, 17–27. [Google Scholar] [CrossRef]
  59. Vázquez, G.H.; Tondo, L.; Mazzarini, L.; Gonda, X. Affective Temperaments in General Population: A Review and Combined Analysis from National Studies. J. Affect. Disord. 2012, 139, 18–22. [Google Scholar] [CrossRef]
  60. Reale, L.; Costantino, M.A.; Sequi, M.; Bonati, M. Transition to Adult Mental Health Services for Young People With ADHD. J. Atten. Disord. 2018, 22, 601–608. [Google Scholar] [CrossRef]
  61. Eke, H.; Ford, T.; Newlove-Delgado, T.; Price, A.; Young, S.; Ani, C.; Sayal, K.; Lynn, R.M.; Paul, M.; Janssens, A. Transition between Child and Adult Services for Young People with Attention-Deficit Hyperactivity Disorder (ADHD): Findings from a British National Surveillance Study. Br. J. Psychiatry 2020, 217, 616–622. [Google Scholar] [CrossRef] [Green Version]
  62. Perugi, G.; Akiskal, H.S. The Soft Bipolar Spectrum Redefined: Focus on the Cyclothymic, Anxious-Sensitive, Impulse-Dyscontrol, and Binge-Eating Connection in Bipolar II and Related Conditions. Psychiatr. Clin. N. Am. 2002, 25, 713–737. [Google Scholar] [CrossRef]
  63. Akiskal, H.S. Delineating Irritable and Hyperthymic Variants of the Cyclothymic Temperament. J. Pers. Disord. 1992, 6, 326–342. [Google Scholar] [CrossRef]
  64. Eich, D.; Gamma, A.; Malti, T.; Vogt Wehrli, M.; Liebrenz, M.; Seifritz, E.; Modestin, J. Temperamental Differences between Bipolar Disorder, Borderline Personality Disorder, and Attention Deficit/Hyperactivity Disorder: Some Implications for Their Diagnostic Validity. J. Affect. Disord. 2014, 169, 101–104. [Google Scholar] [CrossRef] [PubMed]
  65. Perugi, G.; Angst, J.; Azorin, J.-M.; Bowden, C.; Vieta, E.; Young, A.H. The Bipolar-Borderline Personality Disorders Connection in Major Depressive Patients. Acta Psychiatr. Scand. 2013, 128, 376–383. [Google Scholar] [CrossRef] [PubMed]
  66. Perugi, G.; Angst, J.; Azorin, J.-M.M.; Bowden, C.; Vieta, E.; Young, A.H. Is Comorbid Borderline Personality Disorder in Patients with Major Depressive Episode and Bipolarity a Developmental Subtype? Findings from the International BRIDGE Study. J. Affect. Disord. 2013, 144, 72–78. [Google Scholar] [CrossRef]
  67. Perugi, G.; Fornaro, M.; Akiskal, H.S. Are Atypical Depression, Borderline Personality Disorder and Bipolar II Disorder Overlapping Manifestations of a Common Cyclothymic Diathesis? World Psychiatry 2011, 10, 45–51. [Google Scholar] [CrossRef] [PubMed]
Medicina 57 00489 g001 550
Figure 1. Distribution of NE/PE ratio in the sample. Abbreviations: NE/PE = negative emotionality/positive emotionality; SD = standard deviation.
Figure 1. Distribution of NE/PE ratio in the sample. Abbreviations: NE/PE = negative emotionality/positive emotionality; SD = standard deviation.
Medicina 57 00489 g001
Table
Table 1. Differences in sociodemographic variables, psychiatric comorbidity, and family history of psychiatric disorders among patients with ADHD, cyclothymia (CYC), or both (ADHD+CYC). One-way ANOVA was used for age; chi-square tests were used for other variables. F-statistics and χ2-statistics are reported. p-values < 0.05 are shown in bold.
Table 1. Differences in sociodemographic variables, psychiatric comorbidity, and family history of psychiatric disorders among patients with ADHD, cyclothymia (CYC), or both (ADHD+CYC). One-way ANOVA was used for age; chi-square tests were used for other variables. F-statistics and χ2-statistics are reported. p-values < 0.05 are shown in bold.
ADHD (N = 80)ADHD+CYC (N = 25)CYC (N = 60)
Sociodemographic variablesMean (SD)/N (%)Mean (SD)/N (%)Mean (SD)/N (%)χ2/FpPost hoc
Age (years)27.88 (9.69)30.25 (12.53)32.73 (11.74)3.410.036CYC > ADHD
Gender (female)17 (21.3%)15 (60.0%)54 (90.0%)65.670.000CYC > ADHD+CYC > ADHD
Marital status 3.650.456
-  Unmarried68 (85.0%)19 (76.0%)40 (75.5%)
-  Married/cohabiting10 (12.5%)4 (16.0%)8 (15.1%)
-  Separated/divorced2 (2.5%)2 (8.0%)5 (9.4%)
Educational level 26.330.000
-  Primary/middle school28 (35.0%)13 (52.0%)8 (15.1%) ADHD, ADHD+CYC > CYC
-  High school48 (60%)11 (44.0%)29 (54.7%)
-  University4 (5.0%)1 (4.0%)16 (30.2%) CYC > ADHD, ADHD+CYC
Employment 4.420.352
-  Student26 (32.5%)6 (25.0%)20 (37.7%)
-  Unemployed/housekeeper23 (28.8%)11 (45.8%)12 (22.6%)
-  Employed31 (38.8%)7 (29.2%)21 (39.6%)
Psychiatric comorbidity
Bipolar disorder type I11 (13.8%)5 (20.0%)6 (10.0%)1.550.461
Bipolar disorder type II37 (46.3%)3 (12.0%)21 (35.0%)9.750.008ADHD, CYC > ADHD+CYC
Substance use disorders53 (66.3%)14 (56.0%)15 (28.3%)18.590.000ADHD, ADHD+CYC > CYC
Panic disorder12 (15.0%)8 (32.0%)16 (30.2%)5.610.060
Eating disorders17 (21.3%)10 (40.0%)17 (32.1%)4.040.133
First-degree family history
Bipolar disorder39 (48.8%)11 (44.0%)25 (48.1%)0.180.916
Major depressive disorder4 (5.0%)3 (12.0%)12 (23.5%)10.000.007CYC > ADHD
Substance use disorders18 (22.5%)3 (12.0%)4 (7.7%)5.500.064
Panic disorder8 (10.0%)5 (20.0%)15 (28.8%)7.730.021CYC > ADHD
Eating disorders2 (2.5%)1 (4.0%)3 (5.8%)0.920.632
Suicide attempts2 (2.5%)2 (8.0%)8 (15.4%)7.300.026CYC > ADHD
Table
Table 2. Differences in affective temperamental traits (TEMPS-M subscales) and emotional dysregulation facets (RIPoSt-40) among patients with ADHD, cyclothymia (CYC), or both (ADHD+CYC). One-way ANOVA results are displayed. F-statistics are reported. p-values < 0.05 are shown in bold.
Table 2. Differences in affective temperamental traits (TEMPS-M subscales) and emotional dysregulation facets (RIPoSt-40) among patients with ADHD, cyclothymia (CYC), or both (ADHD+CYC). One-way ANOVA results are displayed. F-statistics are reported. p-values < 0.05 are shown in bold.
ADHD (N = 80)ADHD+CYC (N = 25)CYC (N = 60)
Affective temperament (TEMPS-M)Mean (SD)Mean (SD)Mean (SD)FpPost hoc
Depressive21.22 (5.72)22.76 (5.44)25.36 (5.96)8.8160.000CYC > ADHD
Cyclothymic22.63 (6.79)26.24 (6.69)22.92 (6.85)2.8170.063
Hyperthymic21.09 (5.62)20.76 (7.16)17.70 (5.94)5.8460.004ADHD > CYC
Anxious16.04 (5.59)19.37 (7.19)20.64 (6.85)9.5610.000CYC > ADHD
Irritable20.12 (6.88)21.46 (7.05)19.27 (6.35)0.9630.384
Emotional dysregulation (RIPoSt-40)
Affective instability41.82 (11.75)49.44 (12.43)44.66 (12.81)3.8370.024ADHD+CYC > ADHD
Positive emotionality40.38 (8.52)42.48 (10.21)39.85 (9.25)0.7580.470
Negative emotionality39.15 (9.75)39.56 (10.77)44.56 (9.23)5.7230.004CYC > ADHD
Emotional impulsivity30.79 (8.60)31.16 (9.00)29.40 (7.82)0.4530.636
Negative emotional dysregulation111.35 (25.80)120.16 (29.43)118.62 (24.87)1.8440.161
Negative/positive emotionality ratio1.00 (0.35)1.03 (0.63)1.22 (0.55)3.5320.032CYC > ADHD
Table
Table 3. Principal component analysis results (two-component solution). Component loadings of each item in each component are shown. Component loadings > 0.4 are shown in bold.
Table 3. Principal component analysis results (two-component solution). Component loadings of each item in each component are shown. Component loadings > 0.4 are shown in bold.
C1. Negative Affect DysregulationC2. Positive Affect
Affective temperament (TEMPS-M)
Depressive0.78−0.21
Cyclothymic0.760.32
Hyperthymic−0.190.87
Anxious0.680.04
Irritable0.620.44
Emotional dysregulation (RIPoSt-40)
Affective instability0.830.15
Positive emotionality0.210.67
Negative emotionality0.85−0.23
Emotional impulsivity0.730.24
Eigenvalue4.071.67
Variance (%)45.1818.56
Abbreviations: C = component.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Brancati, G.E.; Barbuti, M.; Schiavi, E.; Colombini, P.; Moriconi, M.; Pallucchini, A.; Maiello, M.; Menculini, G.; Perugi, G. Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD. Medicina 2021, 57, 489. https://doi.org/10.3390/medicina57050489

AMA Style

Brancati GE, Barbuti M, Schiavi E, Colombini P, Moriconi M, Pallucchini A, Maiello M, Menculini G, Perugi G. Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD. Medicina. 2021; 57(5):489. https://doi.org/10.3390/medicina57050489

Chicago/Turabian Style

Brancati, Giulio Emilio, Margherita Barbuti, Elisa Schiavi, Paola Colombini, Martina Moriconi, Alessandro Pallucchini, Marco Maiello, Giulia Menculini, and Giulio Perugi. 2021. "Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD" Medicina 57, no. 5: 489. https://doi.org/10.3390/medicina57050489

APA Style

Brancati, G. E., Barbuti, M., Schiavi, E., Colombini, P., Moriconi, M., Pallucchini, A., Maiello, M., Menculini, G., & Perugi, G. (2021). Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD. Medicina, 57(5), 489. https://doi.org/10.3390/medicina57050489

Article Metrics

Back to TopTop